SCHEMBL24869353

SCHEMBL24869353

N#Cc1cc(NC(=O)c2cc(F)c(-c3ccc(F)cc3Cl)cc2Cl)ccn1

nearest known ligand 0.50

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ PPARG P37231 3/20 0.50
▸ SCN10A Q9Y5Y9 3/20 0.44
▸ GRM4 Q14833 1/20 0.43
▸ GRM5 P41594 1/20 0.42
▸ ALDH1A1 P00352 1/20 0.41
▸ MALT1 Q9UDY8 3/20 0.40
▸ NPC1 O15118 3/20 0.40
▸ RAB9A P51151 3/20 0.40
▸ HDAC4 P56524 1/20 0.40
▸ HDAC6 Q9UBN7 1/20 0.40
▸ KIT P10721 1/20 0.40
▸ BRAF P15056 1/20 0.40
▸ HTT P42858 1/20 0.39
▸ RECQL P46063 1/20 0.39
▸ MAPT P10636 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30875083 1.00 PPARG (0.50) PPARGSCN10AGRM4GRM5ALDH1A1
SCHEMBL24869352 0.86 GRM4 (0.47) PPARGGRM4GRM5ALDH1A1NPC1
SCHEMBL30875039 0.86 GRM4 (0.47) PPARGGRM4GRM5ALDH1A1NPC1
SCHEMBL30875010 0.82 SMARCA2 (0.49) PPARGGRM4ALDH1A1MALT1NPC1
SCHEMBL24869346 0.82 SMARCA2 (0.49) PPARGGRM4ALDH1A1MALT1NPC1
SCHEMBL24869358 0.82 MALT1 (0.43) PPARGGRM4ALDH1A1MALT1NPC1
SCHEMBL24869521 0.80 MALT1 (0.51) MALT1
SCHEMBL24869343 0.79 AR (0.49) MALT1
SCHEMBL30875103 0.78 HTR1F (0.40) PPARGGRM4MALT1NPC1RAB9A
SCHEMBL29205937 0.78 HTR1F (0.40) PPARGGRM4MALT1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240336594-A1 SIX-MEMBERED ARYL OR HETEROARYL AMIDES, AND COMPOSITION AND USE THEREOF BETTA PHARMACEUTICALS CO., LTD (CN) 2024-10-10 — — US claimed
EP-4368618-A1 SIX-MEMBERED ARYL OR HETEROARYL AMIDES, AND COMPOSITION AND USE THEREOF Betta Pharmaceuticals Co., Ltd (CN) 2024-05-15 — — EP claimed
CN-117715898-A Six-membered aryl or heteroaryl amide compound, composition and application thereof 贝达药业股份有限公司 2024-03-15 — — CN claimed
WO-2023279986-A1 SIX-MEMBERED ARYL OR HETEROARYL AMIDES, AND COMPOSITION AND USE THEREOF 贝达药业股份有限公司 2023-01-12 — — WO claimed
US-20240336594-A1 SIX-MEMBERED ARYL OR HETEROARYL AMIDES, AND COMPOSITION AND USE THEREOF BETTA PHARMACEUTICALS CO., LTD (CN) 2024-10-10 — — US disclosed
EP-4368618-A1 SIX-MEMBERED ARYL OR HETEROARYL AMIDES, AND COMPOSITION AND USE THEREOF Betta Pharmaceuticals Co., Ltd (CN) 2024-05-15 — — EP disclosed
CN-117715898-A Six-membered aryl or heteroaryl amide compound, composition and application thereof 贝达药业股份有限公司 2024-03-15 — — CN disclosed
WO-2023279986-A1 SIX-MEMBERED ARYL OR HETEROARYL AMIDES, AND COMPOSITION AND USE THEREOF 贝达药业股份有限公司 2023-01-12 — — WO disclosed
WO-2023279986-A1 SIX-MEMBERED ARYL OR HETEROARYL AMIDES, AND COMPOSITION AND USE THEREOF 贝达药业股份有限公司 2023-01-12 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240336594-A1 SIX-MEMBERED ARYL OR HETEROARYL AMIDES, AND COMPOSITION AND USE THEREOF MALT1, CYP51A1, BCR PPARG 4255/4885SCN10A 1676/4885GRM4 4699/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback